IRE1 drives a homeostatic response to reduced protein influx into the endoplasmic reticulum

This study identifies a novel mechanism called TRES (TRanslocon Engagement Surveillance) by which IRE1 senses reduced protein influx into the endoplasmic reticulum via release from unoccupied translocons, triggering a distinct homeostatic response that upregulates the translocation machinery to rebalance ER protein load without activating other UPR branches.

The Gist

The Big Picture: The Cell's "Quality Control" Manager

Imagine your cell is a massive, high-tech factory. Inside this factory, there is a specialized department called the Endoplasmic Reticulum (ER). Think of the ER as the assembly line where proteins (the factory's products) are built and folded into their correct shapes before being shipped out.

To keep this factory running smoothly, the cell has a "Quality Control Manager" named IRE1. For a long time, scientists thought IRE1 only had two jobs:

1. The "Overcrowding" Alarm: If too many products pile up and get crumpled (unfolded proteins), IRE1 sounds the alarm to slow down production and hire more workers.
2. The "Leaky Roof" Alarm: If the factory walls (the membrane) get damaged or the wrong materials are used, IRE1 sounds the alarm to fix the structure.

The New Discovery:
This paper reveals that IRE1 actually has a third job that no one knew about. It acts as a "Silence Detector."

The New Mechanism: TRES (Translocon Engagement Surveillance)

Let's break down the new discovery, which the authors call TRES.

The Analogy: The Empty Train Station

Imagine the ER assembly line is a busy train station.

• The Trains: Ribosomes (machines that build proteins).
• The Tracks: The Translocon (the doorway proteins use to enter the ER).
• The Station Master: IRE1.

Normally, the Station Master (IRE1) stands next to the tracks, holding hands with the trains as they arrive. As long as the trains are constantly arriving and docking, the Station Master is busy and calm. He knows everything is running smoothly.

What happens when production stops?
Imagine a sudden strike or a power outage. The trains stop coming. The tracks become empty.

• Because no trains are docking, the Station Master (IRE1) is suddenly let go. He is no longer holding hands with the tracks.
• The Twist: Instead of relaxing, the Station Master gets panicked. He thinks, "Why are the tracks empty? Something is wrong!"
• He immediately starts shouting orders (activating a gene program) to fix the problem.

The Paper's Finding:
The researchers found that when the flow of new proteins into the ER slows down (due to reduced translation or blocked tracks), IRE1 gets "unplugged" from the tracks. This unplugging triggers IRE1 to activate, even though there are no crumpled proteins and no damaged walls.

Why is this important?

1. It's a "Goldilocks" Sensor:
   The cell doesn't just want to avoid too much stress (overloading); it also needs to avoid too little activity (underloading).

   • Too much traffic: IRE1 says, "Slow down! We have too many broken products!"
   • No traffic: IRE1 says, "Wake up! The assembly line is empty! We need to get ready for a rush!"
   • Just right: IRE1 stays calm.

2. It Links to the "Integrated Stress Response" (ISR):
   The cell has a general "Pause Button" called the ISR. When the cell is stressed (by viruses, lack of nutrients, etc.), it hits this button to stop making proteins.

   • Old View: Stopping protein production was just a way to rest.
   • New View: Stopping protein production actually triggers IRE1 via TRES. The cell stops making proteins, realizes the ER is empty, and IRE1 starts preparing the factory to handle a massive influx of work the moment the "Pause Button" is released. It's like a coach telling the team to rest, but also secretly telling the equipment manager to get the gear ready for the next game.

3. Different Alarms, Different Responses:
   The paper shows that when IRE1 is triggered by "Overcrowding" (classic stress), it sends one set of orders (fix the mess). When triggered by "Silence" (TRES), it sends a different set of orders (upgrade the tracks and hire more loaders). The cell is smart enough to know why the alarm is ringing and responds accordingly.

The "Goldilocks" Zone

The authors describe the ER's ideal state as a "Goldilocks Zone."

• If the ER is too full, it breaks.
• If the ER is too empty, it's inefficient and unprepared.
• IRE1 is the sentinel that watches the door. If the door is clogged, it reacts. If the door is empty, it also reacts. It ensures the factory is always perfectly balanced for whatever the cell needs to do next.

Why should you care?

This discovery changes how we understand diseases like diabetes, Alzheimer's, and cancer.

• Cancer: Some cancer drugs try to block the protein assembly line to starve the tumor. This paper suggests that blocking the line might accidentally trigger IRE1, which could help the cancer cell survive and adapt.
• Neurodegeneration: Many brain diseases involve the "pause button" (ISR) being stuck on. Understanding that this silence triggers IRE1 could lead to new treatments that stop the brain cells from panicking when they aren't making enough proteins.

In a nutshell: The cell's quality control manager doesn't just scream when things go wrong; he also screams when things are too quiet, ensuring the factory is always ready for action.

Technical Summary

1. Problem Statement

The Endoplasmic Reticulum (ER) maintains homeostasis through the Unfolded Protein Response (UPR), a signaling network governed by three sensors: IRE1, PERK, and ATF6.

• Known Mechanisms: IRE1 is traditionally known to activate in two ways:
  1. Unfolded Protein Stress: Binding of unfolded proteins to its luminal domain (or dissociation of the chaperone BiP).
  2. Lipid Bilayer Stress: Sensing changes in membrane composition via its transmembrane domain.
• The Gap: While IRE1 physically associates with the ER translocon (SEC61 complex), ribosomes, and the Signal Recognition Particle (SRP), the functional significance of this association was unclear. Specifically, it was unknown whether IRE1 could sense reduced protein influx (underloading) into the ER, distinct from the well-characterized response to protein overload.

2. Methodology

The authors employed a multidisciplinary approach combining genetic engineering, pharmacology, structural biology, and omics:

• Cell Models: Used U-2 OS (osteosarcoma) and H4 (neuroglioma) cell lines. Crucially, they utilized IRE1$\alpha$-/- U-2 OS cells reconstituted with doxycycline-inducible, mNeonGreen-tagged IRE1 variants to isolate IRE1 activity from endogenous background.
• IRE1 Mutants: Generated specific mutants to dissect activation domains:
  • IRE1$^{WT}$: Wild-type.
  • IRE1$^{TAD}$: Translocon Association Deficient (deletion of residues E434-D443).
  • IRE1$^{DAB}$: "Deaf and Blind" (unable to sense unfolded proteins or lipid stress; retains translocon binding).
  • IRE1$^{BTAD}$: "Blind and Translocon Association Deficient" (lacks luminal domain and translocon motif).
• Pharmacological Interventions:
  • Translocon Inhibitors: SEC61-IN-1 and CADA (to block the translocon pore).
  • Translation Initiation Inhibitors: Rocaglamide A (RocA) and Silvestrol (to reduce ribosome loading on the ER).
  • Translation Elongation Inhibitors: Cycloheximide (CHX) and Emetine (to stabilize ribosome-translocon complexes).
  • ISR Activation: FKBP-PKR homodimerization system and eIF2$\alpha$ phosphomimetic (S51D) to induce the Integrated Stress Response (ISR).
• Assays:
  • XBP1 Splicing: RT-PCR to measure IRE1 RNase activity.
  • Co-Immunoprecipitation (Co-IP): To assess physical interaction between IRE1 and SEC61$\alpha$.
  • RNA Sequencing (RNA-seq): To define gene expression programs.
  • Electron Microscopy (TEM): To visualize ribosome density on ER membranes.
  • In Vivo Models: Mouse liver tissue treated with Zotatifin (a RocA analog).

3. Key Contributions

The paper identifies and characterizes a third, independent mode of IRE1 activation, termed TRES (TRanslocon Engagement Surveillance).

• Mechanism of TRES: TRES is triggered by co-translational translocation deficits. When protein influx into the ER decreases (due to translocon blockage, SRP depletion, or reduced translation initiation), IRE1 dissociates from the SEC61 translocon. This dissociation acts as a "brake release," spontaneously activating IRE1.
• Independence: TRES activation is independent of IRE1's canonical unfolded protein-sensing domain and lipid bilayer-sensing capabilities. It does not require the accumulation of unfolded proteins.
• Distinct Signaling: Unlike the classical UPR (which activates PERK and ATF6), TRES selectively activates IRE1 without triggering PERK or ATF6.
• Unique Gene Program: TRES induces a specific transcriptional program distinct from the classical UPR, focused on upregulating the co-translational translocation machinery (SEC61, SRP, signal peptidases) rather than just chaperones.

4. Key Results

• Dissociation from Translocon Activates IRE1:

  • Cells expressing IRE1$^{TAD}$ (cannot bind translocon) showed high basal XBP1 splicing even without stress, indicating that translocon binding normally represses IRE1.
  • Treatment with SEC61-IN-1 or CADA (translocon blockers) induced XBP1 splicing and IRE1 autophosphorylation. Crucially, this occurred even in cells expressing IRE1$^{DAB}$ (blind to unfolded proteins), proving the mechanism is translocon-dependent, not unfolded-protein-dependent.
  • Co-IP confirmed that translocon inhibitors cause IRE1 to dissociate from SEC61$\alpha$.

• Translation Initiation Block Triggers TRES:

  • Treatment with RocA (translation initiation inhibitor) reduced ribosome density on ER membranes (confirmed by TEM) and caused IRE1 dissociation from the translocon, leading to XBP1 splicing.
  • Conversely, Cycloheximide (elongation inhibitor), which stabilizes ribosomes on translocons, did not activate IRE1. This confirms that TRES specifically senses empty or unoccupied translocons, not just stalled translation.

• Link to the Integrated Stress Response (ISR):

  • Artificially activating the ISR (via FKBP-PKR or eIF2$\alpha$-S51D) reduced translation initiation and activated IRE1 via TRES.
  • This activation was blocked by ISRIB (which reverses eIF2$\alpha$ phosphorylation effects) and did not activate PERK or ATF6.

• Distinct Transcriptional Output:

  • RNA-seq Analysis:
    • Classical UPR (Tm treatment): Upregulated chaperones (HSPA5/BiP), foldases, and ERAD components.
    • TRES (RocA/ISR treatment): Upregulated genes involved in translation, mRNA processing, and specifically the co-translational translocation machinery (SEC61A1/B/G, SRP68/72, SSR, TRAM1).
  • This suggests TRES prepares the cell to handle a future influx of proteins by rebuilding the import machinery, whereas the UPR prepares for current folding overload.

• No Large Oligomers:

  • Unlike the classical UPR, which forms large IRE1 foci (higher-order oligomers), TRES activation did not result in visible IRE1 foci, suggesting a different mode of oligomerization or activation.

5. Significance

• Redefining ER Homeostasis: The study expands the concept of ER stress to include underloading. IRE1 acts as a "Goldilocks" sensor, responding to both too much protein (overload) and too little protein influx (underload) to maintain an optimal "Goldilocks zone" of ER function.
• Physiological Relevance: TRES likely plays a critical role in physiological states where protein synthesis fluctuates, such as B-cell differentiation into plasma cells or endocrine pancreas function, where the ISR is active.
• Therapeutic Implications:
  • Cancer: Many cancers rely on IRE1 activity. Drugs targeting the translocon (e.g., SEC61 inhibitors) or ISR (e.g., ISRIB, Zotatifin) are in clinical trials. Understanding TRES suggests these drugs may activate IRE1 adaptively, potentially conferring resistance or requiring combination therapies.
  • Neurodegeneration: Since ISR dysregulation is linked to neurodegeneration, the TRES pathway may be a critical node in disease pathology where chronic translation suppression leads to maladaptive IRE1 signaling.
• Mechanistic Insight: It resolves the long-standing question of IRE1's association with the translocon, revealing it as a repressive "brake" that is released when translocation deficits occur.

In summary, the paper establishes that IRE1 is a versatile homeostatic sentinel that monitors the rate of protein translocation into the ER, activating a unique, adaptive gene program to rebalance the secretory pathway when protein influx is compromised.